Location History:
- Port Moody, CA (2016 - 2022)
- Anmore, CA (2019 - 2022)
Company Filing History:
9 out of 56 
3 out of 4,447 
1 out of 17 Years Active: 2016-2025
Title: Igor Edmondo Paolo D'Angelo: Innovator in Biopharmaceuticals
Introduction
Igor Edmondo Paolo D'Angelo is a prominent inventor based in Port Moody, Canada. He has made significant contributions to the field of biopharmaceuticals, holding a total of nine patents. His work primarily focuses on developing innovative therapeutic solutions for cancer treatment.
Latest Patents
Among his latest patents is the invention of Anti-PD-L1-anti-TIM-3 bispecific antibodies. This invention relates to heterodimeric antibodies that bind to human PD-L1 and human TIM-3, potentially offering new avenues for cancer treatment, both alone and in combination with chemotherapy and other cancer therapeutics. Another notable patent is for modified antigen binding polypeptide constructs. This invention provides heterodimer pairs that include immunoglobulin heavy and light chains, with specific amino acid modifications to enhance preferential pairing, thereby improving therapeutic efficacy.
Career Highlights
Igor has worked with notable companies in the biopharmaceutical sector, including Zymeworks Inc. and Eli Lilly and Company. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Igor has collaborated with esteemed colleagues such as Surjit Bhimarao Dixit and Mario Sanches. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Igor Edmondo Paolo D'Angelo stands out as an influential inventor in the biopharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing cancer treatment through scientific research and development.